Association between plasma neurofilament light chain levels and cognitive function in patients with Parkinson's disease
Journal of Neuroimmunology, ISSN: 0165-5728, Vol: 358, Page: 577662
2021
- 17Citations
- 52Captures
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations17
- Citation Indexes17
- 17
- CrossRef5
- Captures52
- Readers52
- 52
- Mentions1
- News Mentions1
- 1
Most Recent News
Association between plasma neurofilament light chain levels and cognitive function in patients with Parkinson's disease.
J Neuroimmunol. 2021 Sep 15;358:577662. Epub 2021 Jul 13 Authors: Zhu Y, Yang B, Wang F, Liu B, Li K, Yin K, Yin WF, Zhou C, Tian S, Ren H, Pang A, Yang X PubMed: 34311152 Submit Comment
Article Description
This study investigated the potential association between levels of plasma neurofilament light chain (NfL) and cognitive function in patients suffering from Parkinson's disease (PD) in P.R. China.We collected a total of 168 participants (130 PD patients and 38 healthy controls),and evaluated the relationship of plasma NfL levels with cognitive dysfunction in PD patients. Our results shown that plasma NfL levels increased with an increase in cognitive impairment across the three groups of PD patients: PD with normal cognition (PD-NC), 17.9 ± 8.9 pg/ml; PD with mild cognitive impairment (PD-MCI),21.9 ± 10.3 pg/ml; and PD dementia (PDD), 35.7 ± 21.7 pg/ml. Higher MMSE scores were associated with lower plasma NfL levels ( r = −0.49, 95% CI -0.61 to −0.34, p < 0.0001). Our results associating plasma NfL levels with cognitive dysfunction in PD are consistent with previous studies carried out in several countries/district, based on our meta-analysis.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0165572821001892; http://dx.doi.org/10.1016/j.jneuroim.2021.577662; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85111052143&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/34311152; https://linkinghub.elsevier.com/retrieve/pii/S0165572821001892; https://dx.doi.org/10.1016/j.jneuroim.2021.577662
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know